W Strategies, LLC

W Strategies, LLC filed a Q3 report for Medtronic, Inc. on October 20, 2025, reporting $40,000 in lobbying income.

Lobbying for Medtronic, Inc. · Leader in medical technology providing lifelong solutions for people with chronic pain.

As filed: W STRATEGIES, LLC for MEDTRONIC, INC.

All filings by W Strategies, LLC · Everything Medtronic, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Ensuring Patient Access to Critical Breakthrough Products Act of 2025. CMS coverage of renal derivation devices. Proposed CMS WISER demonstration. Issues related to AI in health care. FY 2026 NDAA as it relates to right to repair legislation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.